Inspections, Compliance, Enforcement, and Criminal Investigations

Twin Falls Biotech LLC - Close Out Letter 7/21/17



Black HHS-Blue FDA Logo


5001 Campus Drive
College Park, MD 20740 


July 21, 2017

David Mouser, CEO
Twin Falls Bio Tech, LLC
18 Margarita Court
Hilton Head Island, SC 29926

Dear Mr. Mouser:

The Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our Warning Letter #444405, issued February 26, 2015. Based on our evaluation, it appears you have addressed the violations contained in the Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.


Latasha A. Robinson, M.S.
Branch Chief
Dietary Supplement and
     Labeling Assessment Branch
Division of Enforcement
Center for Food Safety and Applied Nutrition 

Page Last Updated: 07/24/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English